graft-versus-host disease

6-lung-transplant-patients-got-stem-cells-what-happened

6 Lung Transplant Patients Got Stem Cells: What Happened?

Key Takeaways Six lung transplant patients with advanced chronic lung allograft dysfunction (CLAD) received 251 monthly stem cell infusions, with follow-up up to 58 months. All six survived 24 months, and doctors saw no serious side effects linked to the cells. Lung function did not improve at first, but the

Read More »
New Wharton’s Jelly MSC Study- Why Cell Quality Testing Matters

New Wharton’s Jelly MSC Study: Why Cell Quality Testing Matters

Key Takeaways A 2026 study in Scientific Reports followed 49 patients with steroid-resistant GvHD treated with Wharton’s jelly MSCs at four hospitals in Spain. At day 28, 71.4% of patients responded to treatment. One-year survival reached 55.1%. Batches that scored above 70% on a potency test produced far better outcomes,

Read More »